ESC Congress 2026 Abstract
Heart amyloidosis therapy is linked to lower mortality
Mortality at 24 months was 18% in untreated patients versus 13% in treated patients, with similar benefits in women and men.Mortality at 24 months was 18% in untreated patients versus 13% in treated patients, with similar benefits in women and men.
Cohort · 4,049 peopleInterventions
Who was studied4,049 patients with ATTRwt, 24 months, against untreated patients
What changedMortality at 24 months was lower in treated patients: 13% against 18% in untreated patients
The catchWomen were underrepresented, accounting for only 17% of the analyzed patients
